Maria Bich-Thuy Truong

• Ngo, Elin Thuy Phuong; Truong, Maria Bich-Thuy & Nordeng, Hedvig Marie Egeland (2020). Use of Decision Support Tools to Empower Pregnant Women: Systematic Review. Journal of Medical Internet Research.  ISSN 1438-8871.  22(9) . doi: 10.2196/19436 Fulltekst i vitenarkiv.
• Truong, Maria Bich-Thuy; Ngo, Elin Thuy Phuong; Ariansen, Hilde; Tsuyuki, Ross T. & Nordeng, Hedvig Marie Egeland (2020). The effect of a pharmacist consultation on pregnant women’s quality of life with a special focus on nausea and vomiting: an intervention study. BMC Pregnancy and Childbirth.  ISSN 1471-2393.  20, s 1- 12 . doi: 10.1186/s12884-020-03472-z Fulltekst i vitenarkiv.
• Havnen, Gro Cecilie; Truong, Maria Bich-Thuy; Do, Mai-Linh Huynh; Heitmann, Kristine; Holst, Lone & Nordeng, Hedvig Marie Egeland (2019). Women’s perspectives on the management and consequences of hyperemesis gravidarum – a descriptive interview study. Scandinavian Journal of Primary Health Care.  ISSN 0281-3432.  37(1), s 30- 40 . doi: 10.1080/02813432.2019.1569424 Fulltekst i vitenarkiv.
• Truong, Maria Bich-Thuy; Ngo, Elin Thuy Phuong; Ariansen, Hilde Louise; Tsuyuki, Ross & Nordeng, Hedvig Marie Egeland (2019). Community pharmacist counseling in early pregnancy—Results from the SafeStart feasibility study. PLOS ONE.  ISSN 1932-6203.  14(7), s 1- 14 . doi: 10.1371/journal.pone.0219424 Fulltekst i vitenarkiv. Vis sammendrag

  Background: Community pharmacists are available to counsel women in early pregnancy, but no studies have assessed the feasibility of such a service. Objective: To test the feasibility of a pharmacist consultation in early pregnancy and to inform the design of a definitive trial. Setting: Six community pharmacies in Norway from Oct. to Dec. 2017. Method: We evaluated recruitment approaches and an automatic data preprocessing system (ADPS) to enroll, assign participants, and distribute questionnaires. Women (≥18 years) in early pregnancy were eligible for inclusion. Participants were assigned to a pharmacist consultation (intervention group) or standard care (control group). The intervention aimed to address each woman’s concerns and needs regarding medications and ailments in pregnancy, and was documented on a standard form. The women’s acceptability of the intervention was measured by a questionnaire. Main outcome measures: Appropriate recruitment approaches, workflow of the ADPS, and women’s acceptability of the intervention. Results: Of the 35 participants recruited, 19 were recruited through Facebook. The ADPS worked well. Treatment of nausea and vomiting (NVP) (10/11) and general information about medications (8/11) were frequently discussed during the consultations (n=11). The women reported high satisfaction with the consultation. Having the option of telephone and follow-up consultations was important to the women. Conclusion: It is feasible to provide community pharmacist consultations in early pregnancy. In a definitive study, the consultations should focus on NVP and general medication use and further explore social media as a recruiting tool. Both in-pharmacy and telephone consultations should be offered to deliver the intervention.

• Teigen, Arna; Wang, Siri; Truong, Bich Thuy Ha & Bjerknes, Kathrin (2017). Off-label and unlicensed medicines to hospitalised children in Norway. Journal of Pharmacy and Pharmacology (JPP).  ISSN 0022-3573.  69(4), s 432- 438 . doi: 10.1111/jphp.12581
• Truong, Bich Thuy Ha; Lupattelli, Angela; Kristensen, Petter & Nordeng, Hedvig Marie Egeland (2017). Sick leave and medication use in pregnancy: A European web-based study. BMJ Open.  ISSN 2044-6055.  7(8) . doi: 10.1136/bmjopen-2016-014934 Fulltekst i vitenarkiv. Vis sammendrag

  Background and objective: A comparison of sick leave in pregnancy between countries is difficult as most studies have been conducted in single countries in Scandinavia. The objective of this study was to explore patterns of and reasons for sick leave during pregnancy on a multinational level, focusing on medication use but also differences in sick leave policies. Design and setting: Cross-sectional, web-based study in 12 European countries from October 2011 to February 2012. Data were collected via an electronic questionnaire. Participants Pregnant women and mothers of children under the age of 1 year. Primary outcome measure Sick leave prevalence in pregnancy. Results: Of 6686 women included, 3385 (50.6%) had been on sick leave during pregnancy. The rates of sick leave varied across countries, ranging from 31.7%–34.8% in Sweden and the UK to 62.4%–71.3% in Norway, Serbia, Croatia and Poland. The most common reasons for being on sick leave were pregnancy complications (26.5%); pain in the neck, back or pelvic girdle (16.2%); and nausea and vomiting (NVP, 16.0%). Women using medications for acute illnesses were more likely to be on sick leave than their non-medicated counterparts, while an opposite trend was observed for women with chronic disorders, where non-medicated women were more likely to be on sick leave. Women from countries with ‘low’ sick leave policies were less likely to have extensions of sick leaves compared with women from countries with ‘medium’ policies (adjusted OR 0.63, 95% CI 0.49 to 0.82). Conclusion: The rates of sick leave in pregnancy vary greatly across European countries. Women using medications were more likely to be on sick leave, especially for acute illnesses. The differences in sick leave patterns across countries only partially reflected differences in sick leave policies, which implies that sick leave in pregnancy is also affected by other national differences.

Se alle arbeider i Cristin

• Truong, Bich Thuy Ha & Ariansen, Hilde Louise (2016). Et blikk inn i fremtidens apotek?. Norsk Farmasøytisk Tidsskrift.
• Truong, Bich Thuy Ha; Lupattelli, Angela; Kristensen, Petter & Nordeng, Hedvig Marie Egeland (2016). Sick leave and medication use during pregnancy - a European web-based study.

Se alle arbeider i Cristin